Source: Molecular Therapy. Conference titles: ASGCT Annual Meeting. Unidades: FMRP, ICMC
Subjects: CULTURA DE CÉLULAS, ENZIMAS, DOENÇAS GENÉTICAS, BIOLOGIA SINTÉTICA
ABNT
FIGUEIREDO, Lílian L. S. et al. Addition of histone deacetylase inhibitor in human cell cultures generated by gene therapy and synthetic biology approaches inhibits the secretion of lysosomal enzyme. Molecular Therapy. Cambridge: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 19 maio 2024. , 2021APA
Figueiredo, L. L. S., Wiezel, C. E. V., Tirapelli, D. P. da C., D'Almeida, V., Siciliano, V., Weiss, R., et al. (2021). Addition of histone deacetylase inhibitor in human cell cultures generated by gene therapy and synthetic biology approaches inhibits the secretion of lysosomal enzyme. Molecular Therapy. Cambridge: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Figueiredo LLS, Wiezel CEV, Tirapelli DP da C, D'Almeida V, Siciliano V, Weiss R, Abraham KJ, Gerson SL, Fontes AM. Addition of histone deacetylase inhibitor in human cell cultures generated by gene therapy and synthetic biology approaches inhibits the secretion of lysosomal enzyme. Molecular Therapy. 2021 ; 29( 4): 251.[citado 2024 maio 19 ]Vancouver
Figueiredo LLS, Wiezel CEV, Tirapelli DP da C, D'Almeida V, Siciliano V, Weiss R, Abraham KJ, Gerson SL, Fontes AM. Addition of histone deacetylase inhibitor in human cell cultures generated by gene therapy and synthetic biology approaches inhibits the secretion of lysosomal enzyme. Molecular Therapy. 2021 ; 29( 4): 251.[citado 2024 maio 19 ]